Asset Purchase Agreement Between Faulding Pharmaceutical Co. and NaPro BioTherapeutics, Inc. August 25, 2003Iii Asset Purchase Agreement • August 28th, 2003 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • Delaware
Contract Type FiledAugust 28th, 2003 Company Industry JurisdictionThis Asset Purchase Agreement (this "Agreement") is entered into on August 25, 2003, between Faulding Pharmaceutical Co., a Delaware corporation ("Buyer"), and NaPro BioTherapeutics, Inc., a Delaware corporation ("Seller"). Buyer and Seller are each referred to in this Agreement as a "Party" and collectively as the "Parties."